<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Williams GP</submitter><funding>NIAID NIH HHS</funding><funding>Aligning Science Across Parkinson’s</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>JPB Foundation</funding><pagination>120510</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9950758</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>444</volume><pubmed_abstract>&lt;h4>Background and objectives&lt;/h4>Parkinson's disease (PD) is associated with a heightened inflammatory state, including activated T cells. However, it is unclear whether these PD T cell responses are antigen specific or more indicative of generalized hyperresponsiveness. Our objective was to measure and compare antigen-specific T cell responses directed towards antigens derived from commonly encountered human pathogens/vaccines in patients with PD and age-matched healthy controls (HC).&lt;h4>Methods&lt;/h4>Peripheral blood mononuclear cells (PBMCs) from 20 PD patients and 19 age-matched HCs were screened. Antigen specific T cell responses were measured by flow cytometry using a combination of the activation induced marker (AIM) assay and intracellular cytokine staining.&lt;h4>Results&lt;/h4>Here we s</pubmed_abstract><journal>Journal of the neurological sciences</journal><pubmed_title>Unaltered T cell responses to common antigens in individuals with Parkinson's disease.</pubmed_title><pmcid>PMC9950758</pmcid><funding_grant_id>P50NS108675</funding_grant_id><funding_grant_id>ASAP-000375</funding_grant_id><funding_grant_id>R01 NS095435</funding_grant_id><funding_grant_id>P50 NS108675</funding_grant_id><funding_grant_id>T32AI125179</funding_grant_id><funding_grant_id>T32 AI125179</funding_grant_id><pubmed_authors>Goldman JG</pubmed_authors><pubmed_authors>Mateus J</pubmed_authors><pubmed_authors>Sette A</pubmed_authors><pubmed_authors>Williams GP</pubmed_authors><pubmed_authors>Frazier A</pubmed_authors><pubmed_authors>Sulzer D</pubmed_authors><pubmed_authors>Grifoni A</pubmed_authors><pubmed_authors>Alcalay RN</pubmed_authors><pubmed_authors>Weiskopf D</pubmed_authors><pubmed_authors>Litvan I</pubmed_authors><pubmed_authors>da Silva Antunes R</pubmed_authors><pubmed_authors>Standaert DG</pubmed_authors><pubmed_authors>Muskat K</pubmed_authors><pubmed_authors>Lindestam Arlehamn CS</pubmed_authors><pubmed_authors>Amara AW</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Unaltered T cell responses to common antigens in individuals with Parkinson's disease.</name><description>&lt;h4>Background and objectives&lt;/h4>Parkinson's disease (PD) is associated with a heightened inflammatory state, including activated T cells. However, it is unclear whether these PD T cell responses are antigen specific or more indicative of generalized hyperresponsiveness. Our objective was to measure and compare antigen-specific T cell responses directed towards antigens derived from commonly encountered human pathogens/vaccines in patients with PD and age-matched healthy controls (HC).&lt;h4>Methods&lt;/h4>Peripheral blood mononuclear cells (PBMCs) from 20 PD patients and 19 age-matched HCs were screened. Antigen specific T cell responses were measured by flow cytometry using a combination of the activation induced marker (AIM) assay and intracellular cytokine staining.&lt;h4>Results&lt;/h4>Here we s</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-05-28T12:56:52.641Z</modification><creation>2025-02-19T04:20:53.039Z</creation></dates><accession>S-EPMC9950758</accession><cross_references><pubmed>36495691</pubmed><doi>10.1016/j.jns.2022.120510</doi></cross_references></HashMap>